1. 1. Pérez Abreu, M.R.; Gómez Tejeda, J.J.; Dieguez Guach, R.A. Características clínico epidemiológicas de la COVID-19. Rev. Haban. Cienc. Méd. 2020, 19, e3254.
2. 2. Negrini, S.; Grabljevec, K.; Boldrini, P.; Kiekens, C.; Moslavac, S.; Zampolini, M.; Christodoulou, N. Up to 2.2 million people experiencing disability suffer collateral damage each day of COVID-19 lockdown in Europe. Eur. J. Phys. Rehabil. Med. 2020.
3. 3. Parrado-González, A.; León-Jariego, J.C. Factores asociados al malestar emocional y morbilidad psíquica en población Española [COVID-19: Factors associated with emotional distress and psychological morbidity in spanish population]. Rev. Esp. Salud Pública 2020, 94, e202006058.
4. 4. Ammar, A.; Brach, M.; Trabelsi, K.; Chtourou, H.; Boukhris, O.; Masmoudi, L.; Bouaziz, B.; Bentlage, E.; How, D.; Ahmed, M.; et al. Effects of COVID-19 Home Confinement on Eating Behaviour and Physical Activity: Results of the ECLB-COVID19 International Online Survey. Nutrients 2020, 12, 1583.
5. 5. Balanzá-Martínez, V.; Atienza-Carbonell, B.; Kapczinski, F.; De Boni, R.B. Lifestyle behaviours during the COVID-19-Time to connect. Acta Psychiatr. Scand. 2020, 141, 399-400.